Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
Shanghai Labway Clinical Laboratory Co Ltd
Research & Development
Shanghai Labway Clinical Laboratory Co Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
|
Research & Development
-¥43.3m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Research & Development
-¥2.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Research & Development
-¥201.9m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Research & Development
-¥68.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
Huadong Medicine Co Ltd
SZSE:000963
|
Research & Development
-¥1.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Labway Clinical Laboratory Co Ltd's Research & Development?
Research & Development
-43.3m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Labway Clinical Laboratory Co Ltd's Research & Development amounts to -43.3m CNY.
What is Shanghai Labway Clinical Laboratory Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-26%
Over the last year, the Research & Development growth was 57%. The average annual Research & Development growth rates for Shanghai Labway Clinical Laboratory Co Ltd have been -34% over the past three years , -26% over the past five years .